Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

Share Price is delayed by 15 minutes
Get Live Data
113.50    0.00 (0.00%)
Bid:
110.00
Ask:
117.00
Spread: 7.00 (6.364%)
Market Cap: £15.31m
ITX Live PriceLast checked at - London Stock Exchange

Intraday Itaconix Plc Share Chart

First Bio-based Polymer Application Agreement

26 Jul 2017 14:00

RNS Number : 1460M
Itaconix PLC
26 July 2017
 

26 July 2017

Itaconix plc ("Itaconix")

AkzoNobel and Itaconix finalize first bio-based polymer application agreement

Itaconix has finalized the first application agreement for bio-based polymers to result from its collaboration with AkzoNobel's Specialty Chemicals business, announced earlier this year. This application agreement involves AkzoNobel's Performance Additives unit developing applications for Itaconix polymers to be used in the coatings and construction industries.

"We are pleased to be announcing the first in a series of agreements to develop these polymers for commercial use," said Peter Nieuwenhuizen, RD&I Director for AkzoNobel's Specialty Chemicals business. "Being able to incorporate polymers made from renewable bio-based raw materials will give a significant sustainability advantage for our customers and also fits closely with our own Planet Possible sustainability agenda of doing more with less."

Under the agreement, Itaconix will contribute its proprietary polymers from itaconic acid, which are obtained from sugars through fermentation. Continued Nieuwenhuizen: "In addition to applications in coatings and construction materials, bio-based polymers have the potential to be used in a range of other everyday essentials, ranging from improving water quality to cleaning and hygiene products." Nieuwenhuizen also pointed out that the collaboration with Itaconix is another example of AkzoNobel's approach to embracing open innovation to help find more sustainable solutions.

Dr. Kevin Matthews, CEO of Itaconix, added: "This is the first commercial step in our joint development agreement to collaborate on delivering valuable solutions to AkzoNobel customers with the novel performance of our polymers. We are excited to further strengthen our relationship with AkzoNobel and look forward to combining their deep application knowledge with our unique chemistries to build key product positions in these large and important markets."

 

Ends

For further information please contact:

Itaconix

+44 (0) 1244 283 500

Kevin Matthews / Rob Cridland

N+1 Singer

+44 (0) 207 496 3000

Richard Lindley / Liz Yong (Corporate Finance)

Nick Owen (Corporate Broking)

Hudson Sandler

Charlie Jack / Emily Dillon +44 (0) 207 796 4133

About Itaconix

Itaconix is developing proprietary active ingredients that meet the performance and price needs of its customers and offers them improved safety and sustainability, thereby helping to deliver on the global sustainability agenda, with particular emphasis on the Personal Care and Homecare markets.

www.itaconix.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDMGZNLVVGNZG
Date   Source Headline
9th Feb 20227:00 amRNSFirst Trial for Sustainable Superabsorbent
3rd Feb 20227:00 amRNSNew Patent Filed for Plant-Based Ingredient
26th Jan 20222:05 pmRNSSecond Price Monitoring Extn
26th Jan 20222:00 pmRNSPrice Monitoring Extension
26th Jan 20227:00 amRNSTrading Update
10th Jan 20227:15 amRNSInitiation of Research
22nd Dec 20217:00 amRNSFirst Order for New Use in Sustainable Fashion
21st Dec 20219:05 amRNSSecond Price Monitoring Extn
21st Dec 20219:00 amRNSPrice Monitoring Extension
21st Dec 20217:00 amRNSStatement re Production Resumption
9th Dec 202111:06 amRNSSecond Price Monitoring Extn
9th Dec 202111:00 amRNSPrice Monitoring Extension
4th Nov 20217:00 amRNSProduction Interruption from Storm Damage
1st Oct 20214:41 pmRNSSecond Price Monitoring Extn
1st Oct 20214:36 pmRNSPrice Monitoring Extension
1st Oct 20212:05 pmRNSSecond Price Monitoring Extn
1st Oct 20212:00 pmRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSInterim Results
23rd Sep 20214:41 pmRNSSecond Price Monitoring Extn
23rd Sep 20214:36 pmRNSPrice Monitoring Extension
23rd Sep 20217:00 amRNSNotice of Interim Results & Investor Presentation
16th Sep 202112:13 pmRNSSecond Price Monitoring Extn
16th Sep 202112:12 pmRNSSecond Price Monitoring Extn
16th Sep 202112:12 pmRNSPrice Monitoring Extension
14th Sep 20214:41 pmRNSSecond Price Monitoring Extn
14th Sep 20214:36 pmRNSPrice Monitoring Extension
14th Sep 202111:06 amRNSSecond Price Monitoring Extn
14th Sep 202111:01 amRNSPrice Monitoring Extension
9th Sep 20217:00 amRNSFirst EU Order for Latest Detergent Ingredient
26th Aug 20217:00 amRNSChange of Adviser
27th Jul 20219:05 amRNSSecond Price Monitoring Extn
27th Jul 20219:00 amRNSPrice Monitoring Extension
27th Jul 20217:00 amRNSTrading Statement
19th Jul 202111:05 amRNSSecond Price Monitoring Extn
19th Jul 202111:00 amRNSPrice Monitoring Extension
19th Jul 20217:00 amRNSRemoval of US Securities Law Restrictions
24th Jun 20213:18 pmRNSResult of Annual General Meeting
18th Jun 20217:00 amRNSChanges to AGM Arrangements, Investor Presentation
9th Jun 20219:00 amRNSPrice Monitoring Extension
9th Jun 20217:00 amRNSCompleted New Funding with Institutional Investors
8th Jun 20212:05 pmRNSSecond Price Monitoring Extn
8th Jun 20212:00 pmRNSPrice Monitoring Extension
8th Jun 202111:05 amRNSSecond Price Monitoring Extn
8th Jun 202111:00 amRNSPrice Monitoring Extension
8th Jun 20217:00 amRNSTrading Update
27th May 20217:00 amRNSNotice of AGM
20th May 20214:41 pmRNSSecond Price Monitoring Extn
20th May 20214:35 pmRNSPrice Monitoring Extension
20th May 20217:00 amRNSItaconix receives the LSE's Green Economy Mark
9th Apr 20211:07 pmRNSIssue of Shares, Director/PDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.